Radix Ginseng is the dried root of Panax ginseng C.A. Meyer (Araliaceae) (1–5).1
1 Steamed Panax ginseng root is listed in the Japanese pharmacopoeia as "Red Ginseng (Ginseng Radix Rubra)" (2).
Panax schinseng Nees (2).
Other Panax species, including P. quinquefolius L. (American ginseng), P. notoginseng Burk. (San-chi ginseng), P. pseudoginseng Wall. ssp. japonicus Hara = P. japonicus C.A. Meyer (Japanese chikutsu ginseng) and P. notoginseng ssp. himalaicus (Himalayan ginseng) have also been referred to as "ginseng" and used medically (6, 7). However, scientific documentation of these species is insuffi- cient to justify the preparation of a monograph at this time.
Selected vernacular names
Chosen ninjin, ginseng, Ginsengwurzel, hakusan, hakushan, higeninjin, hongshen, hungseng, hungshen, hunseng, jenseng, jenshen, jinpi, kao-li-seng, korean ginseng, minjin, nhan sam, ninjin, ninzin, niuhuan, Oriental ginseng, otane ninjin, renshen, san-pi, shanshen, sheng-sai-seng, shenshaishanshen, shengshaishen, t'ang-seng, tyosenninzin, yakuyo ninjin, yakuyo ninzin, yehshan- seng, yuan-seng, yuanshen (1, 2, 4–10).
A perennial herb with characteristic branched roots extending from the middle of the main root in the form of a human figure. Stem erect, simple, and not branching. Leaves verticillate, compound, digitate, leaflets 5, with the 3 terminal leaflets larger than the lateral ones, elliptical or slightly obovate, 4–15cm long by 2–6.5 cm wide; apex acuminate; base cuneate; margin serrulate or finely bidentate. In general, 1 leaf in the first year with 1 leaflet added annually until the sixth year. Inflorescence a small terminal umbel, hemispherical in early summer. Flowers polygamous, pink. Calyx vaguely 5-toothed. Petals 5, stamens 5. Fruit a small berry, nearly drupaceous, and red when ripe in autumn (8).
Plant material of interest: dried root
The main root is fusiform or cylindrical, 2.5–20cm long by 0.5–3.0cm in diameter; externally greyish yellow; upper part or entire root exhibiting sparse, shallow, interrupted, and coarse transverse striations and distinct longitudinal wrinkles; lower part bearing 2–5 branching lateral roots and numerous slender rootlets with inconspicuous minute tubercles. Rhizomes 1–4cm long by 0.3– 1.5 cm in diameter, mostly constricted and curved, bearing adventitious roots and sparse depressed circular stem scars. Texture relatively hard, fracture yellowish white, cambium ring brownish yellow, starchy (1–5).
Colour, greyish white to amber-yellow; odour, characteristic; taste, slightly sweet at first, followed by a slight bitterness (1, 2).
The transverse section shows cork consisting of several rows of cells; cortex narrow; phloem showing clefts in the outer part, and parenchymatous cells densely arranged and scattered with resin canals containing yellow secretions in the inner part; cambium in a ring; xylem rays broad, vessels singly scattered or grouped in an interrupted radial arrangement, and occasionally accompanied by non-lignified fibres; parenchyma cells containing abundant starch grains and a few clusters of calcium oxalate (1, 3–5).
Powdered plant material
Yellowish white; fragments of resin canals containing yellow secretions; clusters of calcium oxalate (20–68µm in diameter), few, with acute angles; cork cells subsquare or polygonal, with thin and sinuous walls; reticulate and scalariform vessels 10–56µm in diameter; starch granules fairly abundant, simple, subspheroidal, semicircular, or irregular polygonal (4–30µm in diameter), singly or in groups of two to four (1–5).
Mountain regions of China (Manchuria), the Democratic People's Republic of Korea, Japan, the Republic of Korea, and the Russian Federation (eastern Siberia) (7, 8). It is commercially produced mainly by cultivation (6).
General identity tests
Macroscopic and microscopic examinations, microchemical tests, and thinlayer chromatographic analysis (1–5).
The test for Salmonella spp. in Radix Ginseng products should be negative. The maximum acceptable limits of other microorganisms are as follows (11–13). For preparation of decoction: aerobic bacteria-not more than 107/g; fungi-not more than 105/g; Escherichia coli-not more than 102/g. Preparations for internal use: aerobic bacteria-not more than 105/g or ml; fungi-not more than 104/g or ml; enterobacteria and certain Gram-negative bacteria-not more than 103/g or ml; Escherichia coli-0/g or ml.
Foreign organic matter
Not more than 2% (2, 3).
Not more than 4.2% (2).
Not more than 1% (4).
Not more than 12% (5).
Not less than 14.0% (2).
To be established in accordance with national requirements. Normally, the maximum residue limit of aldrin and dieldrin for Radix Ginseng is not more than 0.05 mg/kg (13). For other pesticides, see WHO guidelines on quality control methods for medicinal plants (11) and guidelines for predicting dietary intake of pesticide residues (14).
Recommended lead and cadmium levels are no more than 10 and 0.3mg/kg, respectively, in the final dosage form of the plant material (11).
For analysis of strontium-90, iodine-131, caesium-134, caesium-137, and plutonium-239, see WHO guidelines on quality control methods for medicinal plants (11).
Other purity tests
Chemical and water-soluble extractive tests to be established in accordance with national requirements.
Microchemical, thin-layer chromatographic, and spectrophotometric methods are used for the qualitative and quantitative analysis of ginsenosides (1–5). High-performance liquid chromatography (15–17) and liquid chromatography– mass spectrometry (18) methods are also available.
Characteristic saponins known as ginsenosides, not less than 1.5% calculated as ginsenoside Rg1 (D-glucopyranosyl-6β-glucopyranosyl-20Sprotopanaxatriol, relative molecular mass 800) (3, 5).
Major chemical constituents
The major chemical constituents are triterpene saponins. More than 30 are based on the dammarane structure, and one (ginsenoside Ro) is derived from oleanolic acid (6, 7, 17, 19). The dammarane saponins are derivatives of either protopanaxadiol or protopanaxatriol. Members of the former group include ginsenosides Ra1-3, Rb1-3, Rc, Rc2, Rd, Rd2, and Rh2; (20S)-ginsenoside Rg3; and malonyl ginsenosides Rb1, Rb2, Rc, and Rd. Examples of protopanaxatriol saponins are ginsenosides Re2, Re3, Rf, Rg1, Rg2, and Rh1; 20- gluco-ginsenoside Rf; and (20R)-ginsenosides Rg2 and Rh1. Those considered most important are ginsenosides Rb1, Rb2, Rc, Rd, Rf, Rg1, and Rg2; Rb1, Rb2, and Rg1 are the most abundant. Representative structures are presented below.
Crude plant material, capsules and tablets of powdered drugs, extracts, tonic drinks, wines, and lozenges. Store in a cool, dry place in well-sealed containers (20).
Uses supported by clinical data
Radix Ginseng is used as a prophylactic and restorative agent for enhancement of mental and physical capacities, in cases of weakness, exhaustion, tiredness, and loss of concentration, and during convalescence (21–29).
Uses described in pharmacopoeias and in traditional systems of medicine
Radix Ginseng has been used clinically in the treatment of diabetes (1), but further clinical studies are needed. The drug is also used in the treatment of impotence, prevention of hepatotoxicity, and gastrointestinal disorders such as gastritis and ulcers (1, 7).
Uses described in folk medicine, not supported by experimental or clinical data
Treatment of liver disease, coughs, fever, tuberculosis, rheumatism, vomiting of pregnancy, hypothermia, dyspnoea, and nervous disorders (7).
The suggested mode of action of Radix Ginseng is twofold. First, the drug has an "adaptogenic" effect (30), which produces a non-specific increase in the body's own defences against exogenous stress factors and noxious chemicals (31). Secondly, the drug promotes an overall improvement in physical and mental performance (30–33).
Treatment of cultured mammalian cells, isolated organs, and animal models (primarily mice and rats) with Radix Ginseng before or during exposure to physical, chemical, or psychological stress increased the ability of the respective model systems to resist the damaging effects of various stressors (31). These results were demonstrated in cases of radiation poisoning (34–36), viral infection and tumour load (37, 38), alcohol or carbon tetrachloride poisoning (39–41), oxygen deprivation and hypobaric pressure (42, 43), light or temperature stress, emotional stress, and electrical shock or restricted movement (44, 45, 46). The mechanism by which the drug exerts its activity is most likely through the hypothalamus–pituitary–adrenal axis (47–49) and through its immunostimulant effect (50).
Intraperitoneal administration to rats of ginseng saponin fractions or the ginsenosides Rb1, Rb2, Rc, Rd, and Re elevated serum levels of adrenocorticotropic hormone (ACTH) and corticosterone (51, 52). Pretreatment with dexamethasone, which blocks hypothalamus and pituitary functions, prevented ginseng saponin-mediated release of ACTH and corticosterone, and thereby demonstrated that the increase in serum corticosterone by ginseng occurs indirectly through release of ACTH from the pituitary (51, 52).
The immunomodulatory activity of ginseng appears to be at least partly responsible for its adaptogenic effect (50, 53, 54). Alcohol extracts of Radix Ginseng stimulated phagocytosis in vitro, were mitogenic in cultured human lymphocytes, stimulated the production of interferon, and enhanced the activity of natural killer cells (55, 56). Intraperitoneal administration of an extract of the drug to mice stimulated cell-mediated immunity against Semliki Forest virus, elevated antibody levels against sheep red blood cells and natural killer cells (57), and stimulated the production of interferon (58).
Improvement in physical and mental performance has been observed in mice and rats after oral or intraperitoneal administration of the drug (59–63). Oral administration of ginseng saponin fractions to mice increased endurance and prolonged swimming time in swimming tests (63). However, two studies concluded that ginseng had no positive effects on the physical performance in mice and rats (64, 65). The adaptogenic effects of Radix Ginseng are generally attributed to the ginsenosides (66, 67). The ginsenosides have been shown to alter mechanisms of fuel homeostasis during prolonged exercise, by increasing the capacity of skeletal muscle to oxidize free fatty acids in preference to glucose for cellular energy production (59). Other constituents of Radix Ginseng, such as vanillic and salicylic acid, have also been reported to have "antifatigue" activity in rats (68). Furthermore, the antioxidant activity of ginseng was associated with both the ginsenosides and the flavonoid constituents (31, 69). The ginsenosides protected pulmonary vascular endothelium against freeradical- induced injury (69).
Mice given ginseng extract or ginsenosides Rb1 and Rg2 orally during passive avoidance response tests showed an improvement in learning ability which was negatively influenced by stress (30), and rats showed improved retention of learned behaviour (70). Ginsenosides Rg1 and Rb1 are the active nootropic constituents of the drug (66), and improve memory and learning in normal as well as cognition-impaired animals. The mode of action involves an increase in the synthesis and release of acetylcholine, and a decrease of brain serotonin levels (66). In cerebral and coronary blood vessels, extracts of Radix Ginseng produced vasodilatation, which improved brain and coronary blood flow (71). The vasodilatory activity of the ginsenosides appears to be primarily due to relaxation of vascular smooth muscles. The ginsenosides block the constricting effects of norepinephrine in isolated aorta strips, and inhibit the uptake of 45Ca2+ in the membrane and sarcolemma of rabbit heart tissue. Inhibition of Ca2+ uptake in the muscle membrane contributes to the mechanism of vasodilatation (71).
A number of polypeptides and glycans isolated from Radix Ginseng, named GP and panaxans A–E, respectively, have demonstrated hypoglycaemic activity when given intraperitoneally to mice (72, 73). Two of the glycans, panaxans A and B, have been shown to stimulate hepatic glucose utilization by increasing the activity of glucose-6-phosphate 1-dehydrogenase, phosphorylase a, and phosphofructokinase (72). Panaxan A did not affect plasma insulin levels or insulin sensitivity, but panaxan B elevated the plasma insulin level by stimulating insulin secretion from pancreatic islets, and further enhanced insulin sensitivity by increasing insulin binding to receptors (72). The panaxans are not active after oral administration. Administration of GP (intravenously or subcutaneously) to mice or rats decreased blood glucose and liver glycogen levels (73). Radix Ginseng also contains a number of other constituents with hypoglycaemic activity (72, 74). Adenosine, isolated from a water extract of Radix Ginseng, enhanced lipogenesis and cyclic AMP accumulation of adipocytes, and some of the ginsenosides inhibited ACTH-induced lipolysis, suppressed insulin-stimulated lipogenesis, and stimulated the release of insulin from cultured islets (72).
Subcutaneous administration of a ginseng extract enhanced the mating behaviour of male rats (75). The drug further stimulated spermatogenesis in rat (76), and rabbit testes, and increased the motility and survival of rabbit sperm outside the body (75).
Intragastric or intradermal administration of an ethanol extract of the drug to rats decreased histamine-, pentagastrin-, carbachol- and vagal stimulationinduced gastric secretion, and inhibited gastric ulcers induced by stress or by pyloric ligation (77–79).
Liver-protectant activity of ginseng has been demonstrated in vitro and in vivo (80, 81). Intraperitoneal administration of Radix Ginseng extracts to normal and dexamethasone-treated rats did not influence the blood chemistry of normal rats, but it decreased aspartate aminotransferase and alanine aminotransferase levels in dexamethasone-treated animals, thereby demonstrating a liverprotectant effect (81). However, another study demonstrated that an intraperitoneal injection of a methanol extract of Radix Ginseng had no protective activity against carbon tetrachloride-induced hepatotoxicity in rats (82).
The results of clinical studies measuring increased performance and antifatigue effects of ginseng extracts are conflicting and, in general, most studies suffer from poor methodology, lack of proper controls, and no standardization of the ginseng extracts used. The influence of chronic Radix Ginseng administration (2 g/day orally for 4 weeks) on substrate utilization, hormone production, endurance, metabolism, and perception of effort during consecutive days of exhaustive exercise in 11 naval cadets was reported. No significant differences were observed between the control group and the group receiving the ginseng supplementation (83). Another clinical trial with eight participants reported no significant difference between placebo and ginseng administration during exhaustive exercise after 7 days of treatment (84). A randomized, double-blind, cross-over study sought the effects of ginseng on circulatory, respiratory, and metabolic functions during maximal exercise in 50 men (21–47 years old) (24). Total tolerated workload and maximal oxygen uptake were significantly higher following ginseng administration than with placebo. At the same workload, oxygen consumption, plasma lactate levels, ventilation, carbon dioxide production, and heart rate during exercise were all lower in the ginseng treatment group. The results indicated that the ginseng preparations effectively increased the work capacity of the participants by improving oxygen utilization (24). A placebo-controlled, cross-over study determined the effects of ginseng on the physical fitness of 43 male triathletes (25). The participants received 200mg of a ginseng preparation twice daily for two consecutive training periods of 10 weeks. No significant changes were observed during the first 10-week period, but ginseng appeared to prevent the loss of physical fitness (as measured by oxygen uptake and oxygen pulse) during the second 10-week period (25). Two further studies with athletes given 100 mg of a standardized ginseng extract twice daily for 9 weeks reported significant improvement in aerobic capacity and reduction in blood lactate and heart rates (26, 27), but placebos or controls were not used in either of the two studies. Further extension of these studies using placebo-controlled, double-blind trials demonstrated significant improvement in the ginseng group as compared with the placebo group (28). Similar results were reported in another study on athletes, and the differences between the ginseng and placebo groups lasted for approximately 3 weeks after the last ginseng dose (29). The effects of 1200mg of Radix Ginseng in a placebocontrolled, double-blind cross-over study in fatigued night nurses were assessed and the results were compared with placebo and with effects on nurses engaged in daytime work (22). Ginseng restored ratings on tests of mood, competence, and general performance, and the study concluded that ginseng had anti-fatigue activity (22).
Aqueous and standardized ginseng extracts were tested in a placebocontrolled, double-blind study for immunomodulatory actions (85). Sixty healthy volunteers were divided into three groups of 20 each and were given either a placebo or 100 mg of aqueous ginseng extract or 100 mg of standardized ginseng extract, every 12 hours for 8 weeks. Blood samples drawn from the volunteers revealed an increase in chemotaxis of polymorphonuclear leukocytes, the phagocytic index, and the total number of T3 and T4 lymphocytes after 4 and 8 weeks of ginseng therapy, as compared with the placebo group. The group receiving the standardized extract also increased their T4: T8 ratio and the activity of natural killer cells. The conclusion of this study was that ginseng extract stimulated the immune system in humans, and that the standardized extract was more effective than the aqueous extract (85).
A double-blind, placebo-controlled clinical study assessed the effect of standardized ginseng extract (100 mg twice daily for 12 weeks) on psychomotor performance in 16 healthy individuals (23). Various tests of pyschomotor performance found a favourable effect on attention, processing, integrated sensory–motor function, and auditory reaction time. The study concluded that the drug was superior to the placebo in improving certain psychomotor functions in healthy subjects (23).
Radix Ginseng has been shown in clinical studies to have beneficial effects in both insulin-dependent and non-insulin-dependent diabetic patients (86, 87). Oral administration of ginseng tablets (200 mg daily for 8 weeks) to 36 noninsulin- dependent patients elevated mood, improved physical performance, reduced fasting blood glucose and serum aminoterminal propeptide of type III procollagen concentrations, and lowered glycated haemoglobin (87).
Ginseng extracts improved sperm production in men and may have some usefulness in treating impotence (32). The ginsenosides, which appear to be the active components, are thought to depress blood prolactin levels, thereby increasing libido (32). In one clinical study, 90 patients with erectile dysfunction were treated with ginseng saponins (600 mg orally per day). Treatment improved rigidity, tumescence, and libido, but not the frequency of coitus (88).
None (21, 50, 89, 90).
No information available.
Diabetic patients should consult a physician prior to taking Radix Ginseng, as ginseng intake may slightly reduce blood glucose levels (86, 87).
There are two reports of an interaction between Radix Ginseng and phenelzine, a monoamine oxidase inhibitor (91, 92). The clinical significance of this interaction has not been evaluated.
Drug and laboratory test interactions
Carcinogenesis, mutagenesis, impairment of fertility
Radix Ginseng is not carcinogenic or mutagenic in vitro, and does not have any effect on fertility (90).
Pregnancy: teratogenic effects
Radix Ginseng is not teratogenic in vivo (90).
Pregnancy: non-teratogenic effects
The safety of Radix Ginseng for use in pregnancy has not been established.
Excretion of Radix Ginseng compounds into breast milk and its effects on the newborn have not been established.
The safety and efficacy of Radix Ginseng use in children have not been established.
Various researchers who studied Radix Ginseng extracts using conventional toxicological methods in five different animal models reported no acute or chronic toxicity of the extract (89, 90, 93).
On the basis of Radix Ginseng's long use, and the relative infrequency of significant demonstrable side-effects, it has been concluded that the use of Radix Ginseng is not associated with serious adverse effects if taken at the recommended dose (90, 93). However, in Siegel's open study of 133 patients ingesting large quantities, ginseng was reported to result in hypertension, nervousness, irritability, diarrhoea, skin eruptions, and insomnia, which were collectively called ginseng abuse syndrome (GAS) (94). Critical analysis of this report has shown that there were no controls or analyses to determine the type of ginseng being ingested or the constituents of the preparation taken, and that some of the amounts ingested were clearly excessive (as much as 15 g per day, where the recommended daily dose is 0.5–2g) (50, 90, 95). When the dose was decreased to 1.7 g/day the symptoms of the "syndrome" were rare. Thus the only conclusion that can be validly extracted from the Siegel study is that the excessive and uncontrolled intake of ginseng products should be avoided (90). One case of ginseng-associated cerebral arteritis has been reported in a patient consuming a high dose of an ethanol extract of ginseng root (approximately 6g in one dose) (96). However, again the type and quantity of ginseng extract were not reported. Two cases of mydriasis and disturbance in accommodation, as well as dizziness have been reported after ingestion of large doses (3–9g) of an unspecified type of ginseng preparation (97).
Estrogenic-like side-effects have been reported in both premenopausal and postmenopausal women following the use of ginseng. Seven cases of mastalgia (98–100) and one case of vaginal bleeding in a postmenopausal woman (101) were reported after ingestion of unspecified ginseng products. An increased libido in premenopausal women has also been reported (100). Specific studies on the possible hormonal side-effects of ginseng have been carried out with a standardized ginseng extract (102–104). Under physiological conditions, there is no interaction of the ginseng extract with either cytosolic estrogen receptors isolated from mature rat uterus or progesterone receptors from human myometrium (102). Furthermore, clinical studies have demonstrated that a standardized ginseng extract does not cause a change in male and female hormonal status (103, 104).
Unless otherwise prescribed, daily dose (taken in the morning): dried root 0.5–2g by decoction; doses of other preparations should be calculated accordingly (21, 23, 89).
1. Pharmacopoeia of the People's Republic of China (English ed.). Guangzhou, Guangdong Science and Technology Press, 1992.
2. The pharmacopoeia of Japan XII. Tokyo, The Society of Japanese Pharmacopoeia, 1991.
3. Pharmacopée française. Paris, Adrapharm, 1996.
4. Deutsches Arzneibuch 1996. Stuttgart, Deutscher Apotheker Verlag, 1996.
5. Pharmacopoeia helvetica VII. Berne, Département fédéral de l'intérieur, 1994.
6. Shibata S et al. Chemistry and pharmacology of Panax. In: Wagner H, Farnsworth NR, Hikino H, eds. Economic and medicinal plants research, Vol. 1. London, Academic Press, 1985.
7. Bruneton J. Pharmacognosy, phytochemistry, medicinal plants. Paris, Lavoisier, 1995.
8. Medicinal plants in China. Manila, World Health Organization, 1989 (WHO Regional Publications, Western Pacific Series, No. 2).
9. Hsu HY. Oriental materia medica, a concise guide. Long Beach, CA, Oriental Healing Arts Institute, 1986.
10. Farnsworth NR, ed. NAPRALERT database. Chicago, University of Illinois at Chicago, IL, August 8, 1995 production (an on-line database available directly through the University of Illinois at Chicago or through the Scientific and Technical Network (STN) of Chemical Abstracts Services).
11. Quality control methods for medicinal plant materials. Geneva, World Health Organization, 1998.
12. Deutsches Arzneibuch 1996. Vol. 2. Methoden der Biologie. Stuttgart, Deutscher Apotheker Verlag, 1996.
13. European pharmacopoeia, 3rd ed. Strasbourg, Council of Europe, 1997.
14. Guidelines for predicting dietary intake of pesticide residues, 2nd rev. ed. Geneva, World Health Organization, 1997 (unpublished document WHO/FSF/FOS/97.7; available from Food Safety, WHO, 1211 Geneva 27, Switzerland).
15. Sticher O, Soldati F. HPLC separation and quantitative determination of ginsenosides from Panax ginseng, Panax quinquefolium and from ginseng drug preparations. 1. Planta medica, 1979, 36:30–42.
16. Sticher O, Soldati F. HPLC separation and quantitative determination of ginsenosides from Panax ginseng, Panax quinquefolium and from ginseng drug preparations. 2. Planta medica, 1979, 39:348–357.
17. Cui JF. Identification and quantification of ginsenosides in various commercial ginseng preparations. European journal of pharmaceutical sciences, 1995, 3:77–85.
18. van Breemen RB et al. Electrospray liquid chromatography/mass spectrometry of ginsenosides. Analytical chemistry, 1995, 67:3985–3989.
19. Sprecher E. Ginseng: miracle drug or phytopharmacon? Deutsche Apotheker Zeitung, 1987, 9:52–61.
20. British herbal pharmacopoeia. London, British Herbal Medicine Association, 1990.
21. German Commission E Monograph, Ginseng radix. Bundesanzeiger, 1991, 11:17 January.
22. Hallstrom C, Fulder S, Carruthers M. Effect of ginseng on the performance of nurses on night duty. Comparative medicine East and West, 1982, 6:277–282.
23. D'Angelo L et al. Double-blind, placebo-controlled clinical study on the effect of a standardized ginseng extract on psychomotor performance in healthy volunteers. Journal of ethnopharmacology, 1986, 16:15–22.
24. Pieralisi G, Ripari P, Vecchiet L. Effects of a standardized ginseng extract combined with dimethylaminoethanol bitartrate, vitamins, minerals, and trace elements on physical performance during exercise. Clinical therapeutics, 1991, 13:373–382.
25. Van Schepdael P. Les effets du ginseng G115 sur la capacité physique de sportifs d'endurance. Acta therapeutica, 1993, 19:337–347.
26. Forgo I, Kirchdorfer AM. The effect of different ginsenoside concentrations on physical work capacity. Notabene medici, 1982, 12:721–727.
27. Forgo I, Kirchdorfer AM. On the question of influencing the performance of top sportsmen by means of biologically active substances. Ärztliche Praxis, 1981, 33:1784–1786.
28. Forgo I. Effect of drugs on physical performance and hormone system of sportsmen. Münchener Medizinische Wochenschrift, 1983, 125:822–824.
29. Forgo I, Schimert G. The duration of effect of the standardized ginseng extract in healthy competitive athletes. Notabene medici, 1985, 15:636–640.
30. Wagner H, Norr H, Winterhoff H. Plant adaptogens. Phytomedicine, 1994, 1:63– 76.
31. Sonnenborn U, Proppert Y. Ginseng (Panax ginseng C.A. Meyer). British journal of phytotherapy, 1991, 2:3–14.
32. Owen RT. Ginseng: A pharmacological profile. Drugs of today, 1981, 17:343–351.
33. Phillipson JD, Anderson LA. Ginseng-quality, safety and efficacy? Pharmaceutical journal, 1984, 232:161–165.
34. Takeda A, Yonezawa M, Katoh N. Restoration of radiation injury by ginseng. I. Responses of X-irradiated mice to ginseng extracts. Journal of radiation research, 1981, 22:323–335.
35. Yonezawa M, Katoh N, Takeda A. Restoration of radiation injury by ginseng. IV. Stimulation of recoveries in CFUs and megakaryocyte counts related to the prevention of occult blood appearance in X-irradiated mice. Journal of radiation research, 1985, 26:436–442.
36. Zhang JS et al. Modification of radiation response in mice by fractionated extracts of Panax ginseng. Radiation research, 1987, 112:156–163.
37. Qian BC et al. Effects of ginseng polysaccharides on tumor and immunological function in tumor-bearing mice. Yao hsueh hsueh pao, 1987, 8:277–280.
38. Yun TK, Yun YS, Han IW. An experimental study on tumor inhibitory effect of red ginseng in mice and rats exposed to various chemical carcinogens. In: Proceedings of the third International Ginseng Symposium. Seoul, Korean Ginseng Research Institute, 1980:87–113.
39. Choi CW, Lee SI, Huk K. Effect of ginseng on hepatic alcohol metabolizing enzyme system activity in chronic alcohol-treated mouse. Korean journal of pharmacognosy, 1984, 20:13–21.
40. Hikino H et al. Antihepatotoxic actions of ginsenosides from Panax ginseng roots. Planta medica, 1985, 51:62–64.
41. Nakagawa S et al. Cytoprotective activity of components of garlic, ginseng and ciwujia on hepatocyte injury induced by carbon tetrachloride in vitro. Hiroshima journal of medical science, 1985, 34:303–309.
42. Chen X et al. Protective effects of ginsenosides on anoxia/reoxygenation of cultured rat monocytes and on reperfusion injuries against lipid peroxidation. Biomedica biochimica acta, 1987, 46:646–649.
43. Lu G, Cheng XJ, Yuan WX. Protective action of ginseng root saponins on hypobaric hypoxia in animals. Yao hsueh hsueh pao, 1988, 9:391–394.
44. Banerjee U, Izquierdo JA. Anti-stress and antifatigue properties of Panax ginseng: Comparison with piracetam. Acta physiologica et therapeutica Latinoamericana, 1982, 32:277–285.
45. Cheng XJ et al. Protective effects of ginsenosides on anoxia/reoxygenation of cultured rat myocytes and on reperfusion injuries against lipid peroxidation. Biomedica biochimica acta, 1987, 46:646–649.
46. Saito H. Neuropharmacological studies on Panax ginseng. In: Chang HM et al., eds. Advances in Chinese medicinal materials research. Singapore, World Scientific Publishing, 1974:509–518.
47. Filaretov AA et al. Effect of adaptogens on the activity of the pituitary-adrenocortical system in rats. Bulletin of experimental biology and medicine, 1986, 101:627–629.
48. Lu G, Cheng XJ, Yuan WX. Effects of the ginseng root saponins on serum corticosterone and brain neurotransmitters of mice under hypobaric and hypoxic environment. Yao hsueh hsueh pao, 1988, 9:489–492.
49. Ng TB, Li WW, Yeung HW. Effects of ginsenosides, lectins, and Momordica charantia insulin-like peptides on corticosterone production by isolated rat adrenal cells. Journal of ethnopharmacology, 1987, 21:21–29.
50. Sonnenborn U. Ginseng-Nebenwirkungen: Fakten oder Vermutungen? Medizinische Monatsschrift für Pharmazeuten, 1989, 12:46–53.
51. Hiai S et al. Stimulation of pituitary-adrenocortical system by ginseng saponin. Endocrinology Japan, 1979, 26:661.
52. Hiai S, Sasaki S, Oura H. Effects of Ginseng saponin on rat adrenal cyclic AMP. Planta medica, 1979, 37:15–19.
53. Singh VK, Agarwal SS, Gupta BM. Immunomodulatory activity of Panax ginseng extract. Planta medica, 1984, 50:462–465.
54. Sonnenborn U. Ginseng-neuere Untersuchungen immunologischer, und endokrinologischer Aktivitäten einer alten Arzneipflanze. Deutsche Apotheker Zeitung, 1987, 125:2052–2055.
55. Fulder S. The growth of cultured human fibroblasts treated with hydrocortisone and extracts of the medicinal plant Panax ginseng. Experimental gerontology, 1977, 12:125–131.
56. Gupta S et al. A new mitogen and interferon inducer. Clinical research, 1980, 28:504A.
57. Singh VK, Agarwal SS, Gupta BM. Immunomodulatory effects of Panax ginseng extract. Planta medica, 1984, 50:459.
58. Jie YH, Cammisuli S, Baggiolini M. Immunomodulatory effects of Panax ginseng C. A. Meyer in the mouse. Agents and actions, 1984, 15:386–391.
59. Avakian EV et al. Effect of Panax ginseng on energy metabolism during exercise in rats. Planta medica, 1984, 50:151–154.
60. Brekhman II, Dardymov IV. Pharmacological investigation of glycosides from ginseng and Eleutherococcus. Journal of natural products, 1969, 32:46–51.
61. Hassan Samira MM et al. Effect of the standardized ginseng extract G 115 on the metabolism and electrical activity of the rabbit's brain. Journal of international medical research, 1985, 13:342–348.
62. Petkov V. Effect of ginseng on the brain biogenic monoamines and 3', 5'-AMP system. Experiments on rats. Arzneimittel-Forschung, 1978, 28:338–339.
63. Bombardelli E, Cristoni A, Lietti A. The effect of acute and chronic ginseng saponins treatment on adrenals function: biochemistry and pharmacological aspects. In: Proceedings of the third International Ginseng Symposium. Seoul, Korean Ginseng Research Institute, 1980:9–16.
64. Lewis WH, Zenger VE, Lynch RG. No adaptogen response of mice to ginseng and Eleutherococcus infusions. Journal of ethnopharmacology, 1983, 8:209–214.
65. Martinez B, Staba EJ. The physiological effects of Aralia, Panax and Eleutherococcus on exercised rats. Japanese journal of pharmacology, 1984, 35:79–85.
66. Liu CX, Xiao PG. Recent advances in ginseng research in China. Journal of ethnopharmacology, 1992, 36:27–38.
67. Yang ZW. Renshen. In: Chang HM, But PPH, eds., Pharmacology and applications of Chinese materia medica, Vol. 1. Singapore, World Scientific Publishing, 1986:17–31.
68. Han BH, Han YN, Park MH. Chemical and biochemical studies on antioxidant components of ginseng. In: Chang HM, Tso WW, Koo A. Advances in Chinese medicinal materials research. World Scientific Publishing, Singapore, 1985:485–498.
69. Kim H et al. Ginsenosides protect pulmonary vascular endothelium against radicalinduced injury. Biochemical and biophysical research communications, 1992, 189, 670– 676.
70. Petkov VD et al. Memory effects of standardized extracts of Panax ginseng (G115), Ginkgo biloba (GK501) and their combination Gincosan (PHL00701). Planta medica, 1993, 59:106–114.
71. Huang KC. Herbs with multiple actions. In: The pharmacology of Chinese herbs. Boca Raton, FL, CRC Press, 1993:21–48.
72. Marles R, Farnsworth NR. Antidiabetic plants and their active constituents. Phytomedicine, 1995, 2:137–189.
73. Wang BX et al. Studies on the mechanism of ginseng polypeptide induced hypoglycemia. Yao hsueh hsueh pao, 1989, 25:727–731.
74. Davydov VV, Molokovsky A, Limarenko AY, Efficacy of ginseng drugs in experimental insulin-dependent diabetes and toxic hepatitis. Patologichezkaia Fiziologiia I Eksperimentalkaia Terapiia, 1990, 5:49–52.
75. Kim C. Influence of ginseng on mating behavior in male rats. American journal of Chinese medicine, 1976, 4:163–168.
76. Yamamoto M. Stimulatory effect of Panax ginseng principals on DNA and protein synthesis in rat testes. Arzneimittel-Forschung, 1977, 27:1404–1405.
77. Suzuki Y et al. Effects of tissue cultured ginseng on the function of the stomach and small intestine. Yakugaku zasshi, 1991, 111:765–769.
78. Suzuki Y et al. Effects of tissue cultured ginseng on gastric secretion and pepsin activity. Yakugaku zasshi, 1991, 111:770–774.
79. Matsuda H, Kubo M. Pharmacological study on Panax ginseng C.A. Meyer. II. Effect of red ginseng on the experimental gastric ulcer. Yakugaku zasshi, 1984, 104:449– 453.
80. Hikino H. Antihepatotoxic activity of crude drugs. Yakugaku zasshi, 1985, 105:109– 118.
81. Lin JH et al. Effects of ginseng on the blood chemistry profile of dexamethasonetreated male rats. American journal of Chinese medicine, 1995, 23:167–172.
82. Kumazawa N et al. Protective effects of various methanol extracts of crude drugs on experimental hepatic injury induced by carbon tetrachloride in rats. Yakugaku zasshi, 1990, 110:950–957.
83. Knapik JJ, Wright JE, Welch MJ. The influence of Panax ginseng on indices of substrate utilization during repeated, exhaustive exercise in man. Federation proceedings, 1983, 42:336.
84. Morris AC, Jacobs I, Kligerman TM. No ergogenic effect of ginseng extract after ingestion. Medical science of sports exercise, 1994, 26:S6.
85. Scaglione F et al. Immunomodulatory effects of two extracts of Panax ginseng C.A. Meyer. Drugs, experimental and clinical research, 1990, 26:537–542.
86. Kwan HJ, Wan JK. Clinical study of treatment of diabetes with powder of the steamed insam (ginseng) produced in Kaesong, Korea. Technical information, 1994, 6:33–35.
87. Sotaniemi EA, Haapakoski E, Rautio A. Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes care, 1995, 18:1373–1375.
88. Choi HK, Seong DW. Effectiveness for erectile dysfunction after the administration of Korean red ginseng. Korean journal of ginseng science, 1995, 19:17–21.
89. Bradley PR, ed. British herbal compendium, Vol. 1. Guildford UK, British Herbal Medicine Association, 1992:115–118.
90. Sonnenborn U, Hänsel R. Panax ginseng. In: De Smet PAGM et al., eds. Adverse reactions of herbal drugs. Springer-Verlag, Berlin, 1992:179–192.
91. Jones BD, Runikis AM. Interaction of ginseng with phenelzine. Journal of clinical psychopharmacology, 1987, 7:201–202.
92. Shader RI, Greenblatt DJ. Phenelzine and the dream machine-ramblings and reflections. Journal of clinical psychopharmacology, 1985, 5:67.
93. Soldati F. Toxicological studies on ginseng. Proceedings of the fourth International Ginseng Symposium. Daejeon, Republic of Korea, Korean Ginseng and Tobacco Research Institute, 1984.
94. Siegel RK. Ginseng abuse syndrome: problems with the panacea. Journal of the American Medical Association, 1979, 241:1614–1615.
95. Tyler V. Performance and immune deficiencies. In: Herbs of choice. New York, Pharmaceutical Products Press, 1994:155–157.
96. Ryu SJ, Chien YY. Ginseng-associated cerebral arteritis. Neurology, 1995, 45:829– 830.
97. Lou BY et al. Eye symptoms due to ginseng poisoning. Yen ko hsueh pao, 1989, 5:96– 97.
98. Palmer BV, Montgomery AC, Monteiro JC. Gin Seng and mastalgia. British medical journal, 1978, 279:1284.
99. Koriech OM. Ginseng and mastalgia. British medical journal, 1978, 297:1556.
100. Punnonen R, Lukola A. Oestrogen-like effect of ginseng. British medical journal, 1980, 281:1110.
101. Hopkins MP, Androff L, Benninghoff AS. Ginseng face cream and unexplained vaginal bleeding. American journal of obstetrics and gynecology, 1988, 159:1121–1122.
102. Buchi K, Jenny E. On the interference of the standardized ginseng extract G115 and pure ginsenosides with agonists of the progesterone receptor of the human myometrium. Phytopharm, 1984:1–6.
103. Forgo I, Kayasseh L, Staub JJ. Effect of a standardized ginseng extract on general well-being, reaction capacity, pulmonary function and gonadal hormones. Medizinische Welt, 1981, 19:751–756.
104. Reinhold E. Der Einsatz von Ginseng in der Gynäkologie. Natur- und Ganzheits Medizin, 1990, 4:131–134.